newsfilter
← Latest News
GlobeNewswire·

InspireMD Reports First Quarter 2026 Financial Results

- Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the CGUARDIANS III clinical trial of its SwitchGuard neuro